The company will offer Ventis Pharma’s patented local anesthetic compound, Endura-KitTM for post-operative surgical and chronic pain management
Amarex Clinical Research guides its client to phase II of FDA trials
Based on a post hoc analysis, fewer required respiratory interventions
Efgartigimod is approved in the United States as VYVGART for the treatment of adults with generalized myasthenia gravis
Cloud-native Alissa data analysis SaaS platform empowers clinical labs and researchers to scale operations with parallel analysis of genomic data
To address the preventive & primary healthcare delivery gaps in India
PharmaLytica Expo to aid in chalking out pharma industry’s $130 Billion growth story by 2030
RH Capital, a leading women's health venture capital fund, announced three new investments to improve health outcomes for women in the US.
The refocused commercial set-up will increase organizational efficiency and alignment across all commercial functions globally
The partnership between Lockwood and Random42 expands the capabilities and geographic footprint for both organizations.
Subscribe To Our Newsletter & Stay Updated
